Dog Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Dog Vaccine Trends and Forecast

The future of the global dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets. The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

A more than 150-page report is developed to help in your business decisions.

Dog Vaccine by Segment

The study includes a forecast for the global dog vaccine by type, age, end use, and region.

Dog Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccine

Dog Vaccine Market by Age [Shipment Analysis by Value from 2018 to 2030]:

• Below 6 Months
• Above 6 Months

Dog Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Veterinary Hospitals & Clinics
• Pet Owners
• Others

Dog Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Dog Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dog vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dog vaccine companies profiled in this report include-

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

Dog Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.

Within this market, veterinary hospital & clinic is expected to witness higher growth over the forecast period.

North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.

Features of the Global Dog Vaccine Market

Market Size Estimates: Dog vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dog vaccine market size by type, age, end use, and region in terms of value ($B).

Regional Analysis: Dog vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, ages, end uses, and regions for the dog vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dog vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the dog vaccine market size?

Answer: The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030.

Q.2 What is the growth forecast for dog vaccine market?

Answer: The global dog vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the dog vaccine market?

Answer: The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

Q4. What are the major segments for dog vaccine market?

Answer: The future of the dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets.

Q5. Who are the key dog vaccine market companies?

Answer: Some of the key dog vaccine companies are as follows:

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

Q6. Which dog vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.

Q7. In dog vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dog vaccine market by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, dna vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?